T2D
T2D now includes a prescriber, compounded medication and delivery. Its older about page describes a different model, so establish current professional roles and monitoring before treatment.
Review by Molly Ward, goal-guide writer · Updated October 2026
The short version
Ask which clinician and pharmacy provide the current service and how care coordinates with your existing diabetes team. A convenience claim does not establish better outcomes or replace a defined clinical plan.
Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
T2D describes a service offering compounded semaglutide and tirzepatide access, focused on type 2 diabetes and prediabetes. The about page identifies Vertical Insight Corp as parent. Its terms refer to T2D Inc and a related limited-liability entity. The current homepage advertises an included prescriber, while the older company explanation favors prescribing by the patient’s existing doctor.
What T2D prescribes, by goal
Weight
- SemaglutideFDA-approved
Listed by the seller; no price we hold.
- TirzepatideFDA-approved
Listed by the seller; no price we hold.
Although the listed ingredients also appear in weight-management care, the current service presents a diabetes and prediabetes focus. Eligibility and clinical goals should be established rather than inferred from a familiar ingredient name. The exact formulation, route and instructions require an actual prescription.
Who prescribes
A licensed clinician
The site does not name the assigned prescriber or a specific medical practice for the new included-prescriber service. The named founders are business and technology leaders, not evidence of the treating professional’s identity. The actual pharmacy is also not identified in these service descriptions. Confirm who evaluates your history, writes prescriptions and manages changes alongside your existing clinician.
The current process describes registration, professional evaluation, pharmacy preparation and continuing support. Regular check-ins are promised without one universal clinical appointment interval or method. The older about page says existing primary or specialist care should retain prescribing responsibility. Ask how the current arrangement resolves that difference and communicates changes to the professionals already treating your condition.
Are labs required?
Not mentioned
A universal testing panel, repeat schedule and included laboratory allowance are not published in the current service description. Ask what baseline information is needed, how glucose and other risks are monitored and who reviews abnormal results. A promise of coordination does not establish those operational details.
Ready to start with T2D?
Prices and plans are set on the seller's own site.
What it claims, and what it cites
The homepage says its integrated model produces better outcomes and fewer complications. The public description does not establish a controlled comparison supporting that service-specific claim. The older about page also makes a long-range shortage prediction, which should not determine current product availability or prescribing. Compounded preparations need their own regulatory and clinical explanation rather than borrowing approval from familiar brand names.
Other products and treatment claims
- Familiar brand references as the current supplied product
- The present homepage specifies compounded medication rather than establishing delivery of the branded examples discussed elsewhere.
How it bills
The service advertises prescriber, medication and delivery together without establishing a complete regular amount. General terms describe recurring membership billing and no partial-period refund. Ask which agreement governs the current combined service and what happens if treatment is declined or later changes. An account cancellation is not automatically a prescription-order refund.
For and against
- For: Diabetes-focused service purpose explained
- For: Current package names care and delivery inclusions
- For: Existing-care coordination discussed
- For: Ongoing support described
- Against: Treating clinician and pharmacy unidentified
- Against: Old and current care models differ
- Against: Monitoring and testing details unresolved
- Against: Service-specific outcome claims need evidence
The evidence behind what it sells
Right for
Someone establishing how a new prescriber coordinates with their existing diabetes care before selecting a compounded preparation.
Look elsewhere if
Someone assuming the founders are treating clinicians or that a combined service guarantees improved health outcomes.
Other sellers for weight
FuturHealth
Also prescribes Semaglutide, Tirzepatide.
Livbetr
Also prescribes Semaglutide, Tirzepatide.
MEDvidi
Also prescribes Semaglutide, Tirzepatide.
T2D
Frequently asked questions
- Is the current included prescriber identified by name?
- No. Confirm the medical practice and individual practitioner before treatment.
- Does the older existing-doctor model clearly explain the new service?
- No. Ask who now prescribes and how information is shared with your existing care team.
- Do familiar brand references identify the actual supplied medication?
- No. The current homepage describes compounded semaglutide and tirzepatide.
Sources
- Current service with prescriber, compounded medication and delivery
- Parent company and older existing-prescriber model
- Subscription billing, account cancellation and service limitations
- Operator and information handling
See what T2D prescribes today
T2D sets its own prices, plans and the states it serves. Check them before you start.